Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: A report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation

Europace

Volumn 17, Issue 1, 2014, Pages 24-31

  Lip, Gregory Y H ^a   Laroche, Cecile ^b   Boriani, Giuseppe ^c   Cimaglia, Paolo ^c   Dan, Gheorghe Andrei ^d   Santini, Massimo ^e   Kalarus, Zbigniew ^f   Rasmussen, Lars Hvilsted ^g,h   Popescu, Mircea Ioachim ⁱ   Tica, Otilia ⁱ   Hellum, Camilla Fragtrup ^g,h   Mortensen, Bettina ^g,h   Tavazzi, Luigi ^j   Maggioni, Aldo P ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b European Society of Cardiology   (France)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^e SAN FILIPPO NERI HOSPITAL   (Italy)

^f MEDICAL UNIVERSITY OF SILESIA   (Poland)

^g AALBORG UNIVERSITY HOSPITAL   (Denmark)

^h AALBORG UNIVERSITY   (Denmark)

ⁱ University of Oradea   (Romania)

^j MARIA CECILIA HOSPITAL   (Italy)

more..

Author keywords

Anticoagulation; Atrial fibrillation; Female; Survey

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; APIXABAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DABIGATRAN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DRONEDARONE; FLECAINIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUTILIDE; INDOBUFEN; PRASUGREL; PROPAFENONE; QUINIDINE; RIVAROXABAN; SOTALOL; THYROID HORMONE; TICAGRELOR; TICLOPIDINE;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ANXIETY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVERSION; CATHETER ABLATION; CHA2 DS2 VASC SCORE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; DISEASE CONTROL; DRUG CONTRAINDICATION; DYSPNEA; EUROPE; FATIGUE; FEAR; FEMALE; HAS BLED SCORE; HEALTH STATUS; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART PALPITATION; HEART SURGERY; HOLTER MONITORING; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MECHANICAL HEART VALVE; MENTAL HEALTH; PACEMAKER IMPLANTATION; PRIORITY JOURNAL; SEX DIFFERENCE; SEXUAL BEHAVIOR; SYMPTOMATOLOGY; THORAX PAIN; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE; AGE DISTRIBUTION; ATRIAL FIBRILLATION; CLINICAL TRIAL; COMORBIDITY; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PILOT STUDY; PREVALENCE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; THROMBOEMBOLISM; TREATMENT OUTCOME; WOMEN'S HEALTH;

AGE DISTRIBUTION; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; CAUSALITY; COMBINED MODALITY THERAPY; COMORBIDITY; ELECTRIC COUNTERSHOCK; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PREVALENCE; RISK FACTORS; THROMBOEMBOLISM; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 84922450086     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu155     Document Type: Article

References (19)

1. Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 2013;34:2746-51
2. Conen D, Chae CU, Glynn RJ, Tedrow UB, Everett BM, Buring JE, et al. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA 2011;305:2080-7
3. Avgil Tsadok M, Jackevicius CA, Rahme E, Humphries KH, Behlouli H, Pilote L. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAMA 2012;307:1952-8
4. Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Levy S, Cobbe S, et al. Genderrelated differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2007;49:572-7
5. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart RhythmAssociation. Europace 2012;14:1385-413
6. Banerjee A, Lane DA, Torp-Pedersen C, Lip GY. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study. Thromb Haemost 2012;107:584-9
7. Potpara TS, Lip GY. Novel oral anticoagulants in non-valvular atrial fibrillation. Best Pract Res Clin Haematol 2013;26:115-29
8. Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, et al. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EurObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot general registry. Europace 2014;16:308-19
9. Chung MK, Shemanski L, Sherman DG, Greene HL, Hogan DB, Kellen JC, et al. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the atrial fibrillation follow-up investigation of rhythm management (affirm) functional status substudy. J Am Coll Cardiol 2005;46:1891-9
10. Nieuwlaat R, Capucci A, Lip GY, Olsson SB, Prins MH, Nieman FH, et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on atrial fibrillation. Eur Heart J 2006;27:3018-26
11. Pisters R, Lane DA, Marin F,CammAJ, LipGY. Stroke and thromboembolism in atrial fibrillation. Circ J 2012;76:2289-304
12. Friberg L, Benson L, Rosenqvist M, LipGY. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. BMJ 2012;344: e3522
13. Mikkelsen AP, Lindhardsen J, Lip GY, Gislason GH, Torp-Pedersen C, Olesen JB. Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study. J Thromb Haemost 2012;10:1745-51
14. Sullivan RM, Zhang J, Zamba G, Lip GY, Olshansky B. Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM). Am J Cardiol 2012;110:1799-802
15. GuoY,Wang H, Zhao X, ZhangY, ZhangD,Ma J, et al. Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation. Int J Cardiol 2013;168:1502-8
16. Friberg J, Scharling H, Gadsboll N, Truelsen T, Jensen GB. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (the Copenhagen City Heart Study). Am J Cardiol 2004;94:889-94
17. Cove CL, Albert CM, Andreotti F, Badimon L, Van Gelder IC, Hylek EM. Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms. Thromb Haemost 2014;111:385-91
18. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, et al. Vitamin K antagonists in heart disease: current status and perspectives (section iii). Position paper of the ESC working group on thrombosis-task force on anticoagulants in heart disease. Thromb Haemost 2013;110:1087-107
19. Gallego P, Roldan V, Marin F, Romera M, Valdes M, Vicente V, et al. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thromb Haemost 2013;110:1189-98